(Q81290162)

English

Phase II trial of individualized rituximab dosing for patients with CD20-positive lymphoproliferative disorders

scientific article published on 18 January 2005

Statements

Phase II trial of individualized rituximab dosing for patients with CD20-positive lymphoproliferative disorders (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit